Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Ivax Research history
Ivax Research company history timeline
Frost formed IVAX Inc. in 1987 as a holding company.
Even without such blockbuster drugs, IVAX should be profitable in 1989 based on some other more reliable products, Lilly writes.
Sinai Medical Center, where he served as chairman of the department until 1990.
1990: North Healthcare Ltd. is acquired.
However, Frost made an even smarter purchase in December 1991 when he bought Goldline Laboratories Inc.
Furthermore, net income exploded to $85 million, a gain of almost 75 percent over 1992.
In fact, had IVAX owned McGaw during 1993 its total revenue would have been nearly $1 billion (as opposed to $645 million). A drawback of the merger was that it earned IVAX a risky credit rating.
Frost made yet another effort to strengthen the company's hold on the generic market in 1995 by merging with Norway-based Hafslund Nycomed.
During 1996, the pharmaceutical industry began to change shape.
In May 1997, IVAX announced plans to name Strauss CEO at its upcoming annual meeting.
In 1999, sales climbed to $656.4 million.
Sales climbed to $793 million in 2000, and that year the company resumed its acquisition strategy with the purchases of Venezuelan firm Laboratorios Elmor S.A. and Wakefield Pharmaceuticals.
2001: Frost is given the National Ernst & Young Entrepreneur of the Year award.
Rate how well Ivax Research lives up to its initial vision.
Ivax Research jobs
Do you work at Ivax Research?
Is Ivax Research's vision a big part of strategic planning?
Ivax Research competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| SOHM | - | $3.5M | 42 | - |
| Prinston Pharm | 2009 | $59.0M | 93 | - |
| Pernix Therapeutics Holdings | 1996 | $146.1M | 171 | - |
| Avion Pharmaceuticals | 2011 | $11.0M | 206 | - |
| Par Pharmaceutical Inc | 2003 | $260.0M | 400 | - |
| US Pharma Lab | 1996 | $202.0M | 150 | 306 |
| Watson Laboratories | 1992 | $37.0M | 50 | - |
| Ani Pharmaceuticals | 1996 | $614.4M | 601 | 27 |
| West-Ward Pharmaceuticals | 1946 | $150.0M | 249 | 54 |
| Coldstream Labs | 2007 | $3.5M | 50 | - |
Ivax Research history FAQs
Zippia gives an in-depth look into the details of Ivax Research, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ivax Research. The employee data is based on information from people who have self-reported their past or current employments at Ivax Research. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ivax Research. The data presented on this page does not represent the view of Ivax Research and its employees or that of Zippia.
Ivax Research may also be known as or be related to IVAX Corporation, IVAX LLC, Ivax, Ivax Pharmaceuticals and Ivax Research.